The image on the left depicts the features most important to FAHR-FaceSurvival’s predictions of cancer survival outcomes, ...
(Biokin) reported positive results from a prespecified interim analysis of the randomized Phase 3 PANKU-Breast01 study ...
Completion of light dose-escalation Part A of Phase 1 study identifies regimen for further evaluation in Part B, supporting advancement of Padeliporfin VTP for treatment of locally advanced pancreatic ...
Every so often in general practice, a run of patients arrive with the same complaint. A few weeks ago, it was frozen shoulder ...
People going through their first episode of psychosis may be especially vulnerable to chatbots that validate distorted ...
Making Strides returns to Howard Park tomorrow to raise funds for breast cancer patients; registration begins at 10 a.m.
About 40 million Americans have diabetes, and that forecast helps explain why treatment has narrowed so quickly to drugs. But ...
An experimental vaccine developed by Merck and Moderna could become the first vaccine of its kind used to treat cancer.
Data being presented at IDWeek 2026 show zoliflodacin maintains high gonorrhea cure rates in patients co-infected with ...
The clinical trial “provides the clearest picture to date on how shorter radiation therapy schedules interact with modern ...
Revolution Medicines said on Friday its recently approved pancreatic cancer drug Rasonque improved overall survival in previously treated patients, regardless of whether they carried an RAS mutation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results